T1	Cluster8 0 33	Calcium phosphate (CaP) materials
T2	Cluster2 261 275	submicrofibres
T4	Entity 401 426	the electrospinning route
T5	Entity 451 481	sintering temperature (1100°C)
T6	Cluster11 497 523	electrospun polymer fibres
T7	Cluster3 536 564	hydroxyapatite nanoparticles
T8	Entity 428 447	A thermal treatment
T9	Entity 574 585	aggregation
T10	Cluster3 589 606	the nanoparticles
T11	Entity 611 619	vaporise
T12	Cluster10 620 638	the polymer matrix
T13	Entity 640 650	The images
T14	Entity 660 679	electron microscopy
T15	Cluster9 694 713	the treated samples
T16	Entity 725 757	their submicrofibrous morphology
T17	Cluster1 889 909	the resulting fibres
T18	Cluster1 976 994	CaP submicrofibres
T19	Cluster11 1070 1088	Electrospun fibres
T20	Entity 1108 1123	a PLGA solution
T21	Cluster3 1149 1165	HA nanoparticles
T22	Entity 1169 1184	Heat treatments
T23	Cluster10 1211 1222	the polymer
T24	Cluster3 1247 1264	the nanoparticles
T25	Entity 1201 1210	evaporate
T26	Entity 1234 1243	sintering
T28	Entity 1324 1345	the sintered scaffold
T29	Cluster2 1389 1403	submicrofibres
T30	Entity 1409 1438	a variety of ceramic material
T31	Entity 1124 1143	highly concentrated
T32	Entity 42 135	synthetic hydroxyapatite (HA, Ca10(PO4)6·(OH)2) and β-tricalcium phosphate (β-TCP, Ca3(PO4)2)
T33	Entity 174 228	bone tissue engineering and drug delivery applications
T34	Cluster1 374 392	CaP submicrofibres
T35	Entity 922 961	hydroxypatite and tricalcium phosphates
T36	Entity 1020 1066	a combination of electrospinning and sintering
T37	Entity 769 808	Fourier transform infrared spectroscopy
T38	Entity 810 827	X-ray diffraction
T39	Entity 832 864	X-ray photoelectron spectroscopy
T40	Entity 1227 1233	induce
T41	Entity 304 326	their biocompatibility
T45	Entity 1268 1281	Hydroxypatite
T48	Cluster8 304 309	their
T49	Cluster9 725 730	their
T50	Cluster8 155 160	their
